Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2016-09, Vol.27, p.iv4 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | iv4 |
| container_title | Annals of oncology |
| container_volume | 27 |
| creator | Normanno, N. Rachiglio, A.M. Lambiase, M. Fenizia, F. Iannaccone, A. Chicchinelli, N. Morabito, A. Rocco, G. Galetta, D. Montagna, E.S. Crinò, L. Ludovini, V. Vincenzi, B. Barletta, E. Pinto, C. Ferraù, F. Botti, G. Piccirillo, M.C. Perrone, F. |
| description | |
| doi_str_mv | 10.1093/annonc/mdw332.03 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw332_03</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdw332_03</sourcerecordid><originalsourceid>FETCH-LOGICAL-c833-8f3d92a4d04b80d2b367df57d0449835a3b453ec66cd31f16b340a8c9757bfc3</originalsourceid><addsrcrecordid>eNotUMtuwjAQzKGVSh_3HvcIh4CTzfNYIaCoqJUK98hx1uCWOJFtivixfl8d0cs-ZndHsxMEzxGbRqzEGde602LWNmfEeMrwJhixMsYwTzG5C-6t_WKMZWVcjoLf3antDBzIken2pEm5C3ApSTgL7kDAhVM_A9hJoF41ZFp-hL3pzu4A0k_9tSFB_VCMF6vl5wTcxXRWaYJvpbklUPqgauUXLIx3b2s78QgMq9CeHNcOvNzQet4jCPLheNJ7EFwL8pTv2_lmPoGeO0Xaixr3zk4eg1vJj5ae_vNDsF0udvPXcPOxWs9fNqEoEMNCYlPGPGlYUhesiWvM8kamue-TssCUY52kSCLLRIORjLIaE8YLUeZpXkuBDwG7sgr_jzUkq96olptLFbFqcLq6Ol1dna4Y4h-ASnjM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Normanno, N. ; Rachiglio, A.M. ; Lambiase, M. ; Fenizia, F. ; Iannaccone, A. ; Chicchinelli, N. ; Morabito, A. ; Rocco, G. ; Galetta, D. ; Montagna, E.S. ; Crinò, L. ; Ludovini, V. ; Vincenzi, B. ; Barletta, E. ; Pinto, C. ; Ferraù, F. ; Botti, G. ; Piccirillo, M.C. ; Perrone, F.</creator><creatorcontrib>Normanno, N. ; Rachiglio, A.M. ; Lambiase, M. ; Fenizia, F. ; Iannaccone, A. ; Chicchinelli, N. ; Morabito, A. ; Rocco, G. ; Galetta, D. ; Montagna, E.S. ; Crinò, L. ; Ludovini, V. ; Vincenzi, B. ; Barletta, E. ; Pinto, C. ; Ferraù, F. ; Botti, G. ; Piccirillo, M.C. ; Perrone, F.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdw332.03</identifier><language>eng</language><ispartof>Annals of oncology, 2016-09, Vol.27, p.iv4</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Normanno, N.</creatorcontrib><creatorcontrib>Rachiglio, A.M.</creatorcontrib><creatorcontrib>Lambiase, M.</creatorcontrib><creatorcontrib>Fenizia, F.</creatorcontrib><creatorcontrib>Iannaccone, A.</creatorcontrib><creatorcontrib>Chicchinelli, N.</creatorcontrib><creatorcontrib>Morabito, A.</creatorcontrib><creatorcontrib>Rocco, G.</creatorcontrib><creatorcontrib>Galetta, D.</creatorcontrib><creatorcontrib>Montagna, E.S.</creatorcontrib><creatorcontrib>Crinò, L.</creatorcontrib><creatorcontrib>Ludovini, V.</creatorcontrib><creatorcontrib>Vincenzi, B.</creatorcontrib><creatorcontrib>Barletta, E.</creatorcontrib><creatorcontrib>Pinto, C.</creatorcontrib><creatorcontrib>Ferraù, F.</creatorcontrib><creatorcontrib>Botti, G.</creatorcontrib><creatorcontrib>Piccirillo, M.C.</creatorcontrib><creatorcontrib>Perrone, F.</creatorcontrib><title>Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNotUMtuwjAQzKGVSh_3HvcIh4CTzfNYIaCoqJUK98hx1uCWOJFtivixfl8d0cs-ZndHsxMEzxGbRqzEGde602LWNmfEeMrwJhixMsYwTzG5C-6t_WKMZWVcjoLf3antDBzIken2pEm5C3ApSTgL7kDAhVM_A9hJoF41ZFp-hL3pzu4A0k_9tSFB_VCMF6vl5wTcxXRWaYJvpbklUPqgauUXLIx3b2s78QgMq9CeHNcOvNzQet4jCPLheNJ7EFwL8pTv2_lmPoGeO0Xaixr3zk4eg1vJj5ae_vNDsF0udvPXcPOxWs9fNqEoEMNCYlPGPGlYUhesiWvM8kamue-TssCUY52kSCLLRIORjLIaE8YLUeZpXkuBDwG7sgr_jzUkq96olptLFbFqcLq6Ol1dna4Y4h-ASnjM</recordid><startdate>201609</startdate><enddate>201609</enddate><creator>Normanno, N.</creator><creator>Rachiglio, A.M.</creator><creator>Lambiase, M.</creator><creator>Fenizia, F.</creator><creator>Iannaccone, A.</creator><creator>Chicchinelli, N.</creator><creator>Morabito, A.</creator><creator>Rocco, G.</creator><creator>Galetta, D.</creator><creator>Montagna, E.S.</creator><creator>Crinò, L.</creator><creator>Ludovini, V.</creator><creator>Vincenzi, B.</creator><creator>Barletta, E.</creator><creator>Pinto, C.</creator><creator>Ferraù, F.</creator><creator>Botti, G.</creator><creator>Piccirillo, M.C.</creator><creator>Perrone, F.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201609</creationdate><title>Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)</title><author>Normanno, N. ; Rachiglio, A.M. ; Lambiase, M. ; Fenizia, F. ; Iannaccone, A. ; Chicchinelli, N. ; Morabito, A. ; Rocco, G. ; Galetta, D. ; Montagna, E.S. ; Crinò, L. ; Ludovini, V. ; Vincenzi, B. ; Barletta, E. ; Pinto, C. ; Ferraù, F. ; Botti, G. ; Piccirillo, M.C. ; Perrone, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c833-8f3d92a4d04b80d2b367df57d0449835a3b453ec66cd31f16b340a8c9757bfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Normanno, N.</creatorcontrib><creatorcontrib>Rachiglio, A.M.</creatorcontrib><creatorcontrib>Lambiase, M.</creatorcontrib><creatorcontrib>Fenizia, F.</creatorcontrib><creatorcontrib>Iannaccone, A.</creatorcontrib><creatorcontrib>Chicchinelli, N.</creatorcontrib><creatorcontrib>Morabito, A.</creatorcontrib><creatorcontrib>Rocco, G.</creatorcontrib><creatorcontrib>Galetta, D.</creatorcontrib><creatorcontrib>Montagna, E.S.</creatorcontrib><creatorcontrib>Crinò, L.</creatorcontrib><creatorcontrib>Ludovini, V.</creatorcontrib><creatorcontrib>Vincenzi, B.</creatorcontrib><creatorcontrib>Barletta, E.</creatorcontrib><creatorcontrib>Pinto, C.</creatorcontrib><creatorcontrib>Ferraù, F.</creatorcontrib><creatorcontrib>Botti, G.</creatorcontrib><creatorcontrib>Piccirillo, M.C.</creatorcontrib><creatorcontrib>Perrone, F.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Normanno, N.</au><au>Rachiglio, A.M.</au><au>Lambiase, M.</au><au>Fenizia, F.</au><au>Iannaccone, A.</au><au>Chicchinelli, N.</au><au>Morabito, A.</au><au>Rocco, G.</au><au>Galetta, D.</au><au>Montagna, E.S.</au><au>Crinò, L.</au><au>Ludovini, V.</au><au>Vincenzi, B.</au><au>Barletta, E.</au><au>Pinto, C.</au><au>Ferraù, F.</au><au>Botti, G.</au><au>Piccirillo, M.C.</au><au>Perrone, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts)</atitle><jtitle>Annals of oncology</jtitle><date>2016-09</date><risdate>2016</risdate><volume>27</volume><spage>iv4</spage><pages>iv4-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdw332.03</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2016-09, Vol.27, p.iv4 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdw332_03 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Tumor heterogeneity affects the activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant non-small cell lung cancer (NSCLC) patients (pts) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T00%3A56%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20heterogeneity%20affects%20the%20activity%20of%20epidermal%20growth%20factor%20receptor%20(EGFR)%20tyrosine%20kinase%20inhibitors%20(TKIs)%20in%20EGFR%20mutant%20non-small%20cell%20lung%20cancer%20(NSCLC)%20patients%20(pts)&rft.jtitle=Annals%20of%20oncology&rft.au=Normanno,%20N.&rft.date=2016-09&rft.volume=27&rft.spage=iv4&rft.pages=iv4-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdw332.03&rft_dat=%3Ccrossref%3E10_1093_annonc_mdw332_03%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |